• RWD12 Wayfind-R: A Global, Real-World Precision Oncology Registry – Socioeconomic Features

    Dec 1, 2023, 00:00

  • HPR148 Bio-Hybrid Medicinal Products: Widening Access or Product Differentiation?

    Dec 1, 2023, 00:00

  • RWD138 Rising Adoption of Healthcare Wearables in Clinical Study Design

    Dec 1, 2023, 00:00

  • SA8 The Use of Care Pathway Analysis to Inform Health Economic Models and Evidence Generation Requirements: Practical Applications and Examples from Two Projects

    Dec 1, 2023, 00:00

  • HTA6 The Value of Looking Beyond Overall Survival: The Role of Oncology-Relevant Endpoints in HTA / Payer Decision-Making

    Dec 1, 2023, 00:00

  • MSR88 Validation of a Programmed Probability Score Using the Screening Tool, Sympro to Assist Selection of Studies in Systematic Literature Reviews

    Dec 1, 2023, 00:00

  • PCR251 Economic and Humanistic Burden of Visual Impairment and Blindness in Patiens and Their Caregivers with Retinitis Pigmentosa or Leber Congenital Amaurosis (E-BIRDS Study)

    Dec 1, 2023, 00:00

  • PCR86 Estimating Health-Related Quality of Life in Fabry Disease for Patients Treated with Enzyme-Replacement Therapy in the BALANCE Randomized Controlled Trial

    Dec 1, 2023, 00:00

  • EE579 Cost Consequences of Using Clevidipine in Neurological Emergencies from the Perspective of a US Hospital

    Dec 1, 2023, 00:00

  • HSD86 Economic Attributes of Caregiver Burden Among Schizophrenia Patients: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • EPH135 Years of Life Lost and Productivity Costs Due to Premature Cancer-Related Mortality in Egypt

    Dec 1, 2023, 00:00

  • PCR239 Quality of Life (QOL) Instruments Used in Clinicaltrials.gov-Indexed Trials of Gene-Modified Cell Therapy (GMCT) in Patients With Multiple Myeloma (MM)

    Dec 1, 2023, 00:00

  • EPH70 Claims Data Analysis of Health Care Resource Use and Costs of Respiratory Syncytial Virus Prevention in Infants in Germany

    Dec 1, 2023, 00:00

  • EE134 Pharmacoeconomic Evaluation of National Immunization Program Realisation in Algeria

    Dec 1, 2023, 00:00

  • RWD51 Application of Real-World Data Sources for Equity-Informed Evaluations of Multiple Myeloma

    Dec 1, 2023, 00:00

  • MT68 Digital Therapeutics (DTx) for Alzheimer's Disease, Dementia and Mild Cognitive Impairment: A Pragmatic Review of Clinical Evidence

    Dec 1, 2023, 00:00

  • HTA63 Qualitative Analysis of Value-Based Contract Experience, Perception, and Future Adoption across Geographies

    Dec 1, 2023, 00:00

  • MSR139 Performance of Different Survival Models for Extrapolation of Immature OS Data for 2L+ NSCLC Therapies

    Dec 1, 2023, 00:00

  • RWD106 The Maze of RWE Frameworks: An Environmental Scanning and Comparison Across Regulatory and HTA Bodies

    Dec 1, 2023, 00:00

  • RWD61 Inclusion of Productivity Losses and Gains in Cost-Effectiveness Analyses in Psoriasis: Preliminary Report of a Brazilian Association of Psoriasis (LATAM/LMIC)

    Dec 1, 2023, 00:00

  • SA7 Emerging Biomarkers in Metastatic Castration Resistant Prostate Cancer As Evaluated in Early Phase Clinical Trials: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • PCR134 Listening and Learning from the Voices of Patients with Myelodysplastic Syndromes and Their Caregivers: A Comprehensive Social Media Analysis Using Machine Learning and Natural Language Processing-Based Algorithms

    Dec 1, 2023, 00:00

  • HTA128 Use of Patient Preference Studies in NICE Submissions in the Last 5 Years

    Dec 1, 2023, 00:00

  • PCR232 Psychometric Properties of a Patient Reported Outcome Measure (PROM) Evaluating Patient Autonomy in Multiple Sclerosis (MS)

    Dec 1, 2023, 00:00

  • HPR89 Payer Rejections and Prescription Abandonment Among Patients Newly Prescribed Oral Anticoagulants for Venous Thromboembolism

    Dec 1, 2023, 00:00

  • EE204 Saving Lives through Early Access: Exploring the Impact of a Managed Access Agreement in Adjuvant EGFRm NSCLC

    Dec 1, 2023, 00:00

  • HTA50 Assessing the Risk of Bias in Clinical Trials for Health Technology Assessments: Should Existing Tools Reflect the ICH E9(R1) Addendum on Estimands and Sensitivity Analyses?

    Dec 1, 2023, 00:00

  • CO65 Modelled Impact of Nirsevimab for All Infants in the Prevention of Respiratory Syncytial Virus (RSV): Related Hospitalizations and Its Predicted Cost to the Brazilian Public Healthcare System

    Dec 1, 2023, 00:00

  • EE467 Cost-Effectiveness and Budget Impact Analyses Using Real World Data from Brazilian Health Care Insurance Companies in the Treatment of Iron Deficiency in Patients with Heart Failure

    Dec 1, 2023, 00:00

  • EE355 Pre-Progression Health State Utility Values From the TALAPRO-2 Clinical Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With HRR Mutations

    Dec 1, 2023, 00:00

  • HTA219 Examining the Awareness and Perceptions of EU HTA Amongst Irish Pharmaceutical Industry Professionals

    Dec 1, 2023, 00:00

  • EE402 Cost Effectiveness Analysis of Levonorgestrel Vs Etonorgestrel in Contraception from the Mexican Context

    Dec 1, 2023, 00:00

  • HSD100 Opportunities and Barriers to Hub-and-Spoke Delivery Models for Advanced Therapy Medicinal Products in Europe: A Scoping Review

    Dec 1, 2023, 00:00

  • MT17 Cost and Resource Use Outcomes for Left Atrial Appendage Occlusion Patients Contraindicated to Transesophageal Echocardiography

    Dec 1, 2023, 00:00

  • MT40 Trends of Use of Knotless Tissue Control Devices and Smooth Sutures in Robotic Ventral Hernia Repair: A Retrospective Database Analysis

    Dec 1, 2023, 00:00

  • EPH25 Impact of Cancer Deaths on Years of Life and Productivity Losses in Japan in 2019

    Dec 1, 2023, 00:00

  • EPH138 Descriptive Analysis of Communication About Cancer Prevention and Screening on the Social Network Twitter

    Dec 1, 2023, 00:00

  • EE37 Method Matters: Cost-Minimization Versus Cost-Effectiveness Frameworks in Assessing Opioid Use Disorder Treatments

    Dec 1, 2023, 00:00

  • HPR143 Standardizing Cross-Border Access to Advanced Therapies

    Dec 1, 2023, 00:00

  • MSR59 Does Interval Time-Trade-Off Reduce Satisfying Effects and Inconsistencies in Valuation Studies?

    Dec 1, 2023, 00:00

  • EE183 Cost-Effectiveness of Raltegravir Oral Granules Prophylaxis in Neonates to Prevent HIV Mother-to-Child Transmission in Brazil

    Dec 1, 2023, 00:00

  • PT33 Cost-Effectiveness of Pembrolizumab Plus Chemotherapy, With or Without Bevacizumab for the First-Line Treatment of PD-L1-Positive Patients With Persistent, Recurrent, or Metastatic Cervical Cancer in France

    Dec 1, 2023, 00:00

  • EPH144 Annual Health Insurance Treatment Cost of Female Infertility, Unspecified Based on Routinely Collected Financing Data Between 2010-2019

    Dec 1, 2023, 00:00

  • MSR114 Reducing Mortality From Malignant Neoplasms: The Promising Role of Modern Antineoplastic Drugs in Lung Cancer Treatment

    Dec 1, 2023, 00:00

  • EPH179 Ibuprofen, Other Nsaids, COVID-19: A Narrative Review

    Dec 1, 2023, 00:00

  • MT2 Description of Portal Hypertension Treatment by Transjugular Intrahepatic Portosystemic Shunt: A French National Hospital Database Analysis

    Dec 1, 2023, 00:00

  • HSD91 High Costs, Low Quality of Life, Reduced Survival, and Room for Improving Treatment: An Analysis of Burden and Unmet Needs in Glioma

    Dec 1, 2023, 00:00

  • SA61 Economic Burden of Patients in the United States with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Focused Literature Review

    Dec 1, 2023, 00:00

  • EE591 Impact of Flu Vaccine Shortage on the National Health Service (NHS) in England and Wales

    Dec 1, 2023, 00:00

  • EE304 Estimating Health Related Quality of Life Effects in Vitiligo: Mapping EQ-5D-5L Utilities from Vitiligo Specific Scales, Re-Pigmentation Measures Using Data from the HI-Light Trial

    Dec 1, 2023, 00:00

  • SA15 A Systematic Review to Assess How Cure Is Modelled and Subsequently Evaluated in Health Technology Submissions to the National Institute for Health and Care Excellence (NICE)

    Dec 1, 2023, 00:00

  • RWD144 Coded Diagnoses Versus Proxy-Based Diagnoses in Primary Care: Registration By General Practitioners in the PHARMO GP Data

    Dec 1, 2023, 00:00

  • EE471 Investigating the Impact of Pseudo-Random Numbers Generator on a Probabilistic Sensitive Analysis (PSA) Results

    Dec 1, 2023, 00:00

  • EE197 Cost-Effectiveness Analysis of Spinal Cord Stimulation in Sweden

    Dec 1, 2023, 00:00

  • HPR96 Pieces: Productivity Losses Due to Premature Mortality From Cancer in Greece

    Dec 1, 2023, 00:00

  • MSR21 Methodological Aspects of a COVID-19 Vaccine Discrete Choice Experiment Survey in Canada, Germany, UK, and US General Populations

    Dec 1, 2023, 00:00

  • PT42 The Impact of Spinal Muscular Atrophy Type 2 on Caregivers in Argentina: Results of a Global Survey

    Dec 1, 2023, 00:00

  • EE310 Botulinum Toxin Type a for the Treatment of Patients with Post-Stroke Focal Spasticity in Thailand: A Cost-Utility Analysis

    Dec 1, 2023, 00:00

  • HTA263 NICE Listens: Engaging the Public on How Environmental Sustainability Should Be Considered in Health Technology Assessment and Guideline Development

    Dec 1, 2023, 00:00

  • EE446 Cost-Effectiveness Analysis of Nuvaxovid Vaccination for Japanese Elderly Population

    Dec 1, 2023, 00:00

  • RWD99 Characterization of Comorbidities and Economic Burden in US Medicare Beneficiaries with Systemic Lupus Erythematosus with and without Lupus Nephritis

    Dec 1, 2023, 00:00

  • HPR199 To Operationalize the VBHC in the Medical Device Area – An Italian Experience

    Dec 1, 2023, 00:00

  • EE26 Deprescribing of Proton Pump Inhibitors in Elderly Patients: A Cost-Effectiveness Analysis

    Dec 1, 2023, 00:00

  • PCR143 European Quality of Life Five Dimension (EQ-5D) Utility Values for Clinical Health States in Fabry Disease (FD): Insights from Pegunigalsidase Alpha Clinical Trials

    Dec 1, 2023, 00:00

  • HTA87 Mapping Accumulating Evidence Across Multiple Indications in Oncology Health Technology Assessment

    Dec 1, 2023, 00:00

  • EE117 Cost-Effectiveness of Empagliflozin in Patients Affected By Chronic Kidney Disease in Italy

    Dec 1, 2023, 00:00

  • P2 NICE's Pathways Pilot: Incorporating Disease-Specific Reference Models Into Health Technology Assessment in England

    Dec 1, 2023, 00:00

  • EPH181 Are Social Networks Harming Our Teens? Assessing the Plausibility of a Link between Social Network Use and Depression Using a Microsimulation Model

    Dec 1, 2023, 00:00

  • PCR227 Do Family Spillover Effects of Illness Vary With the Age of the Ill Individual?

    Dec 1, 2023, 00:00

  • PCR231 The Socio-Economic Burden on Caregivers of Pediatric Autistic Population in Europe: A Systematic Review

    Dec 1, 2023, 00:00

  • HSD69 Maternal and Foeto-Neonatal Characteristics of Childbirths in Ethiopia: A Multilevel Mixed-Effect Analysis

    Dec 1, 2023, 00:00

  • EE535 Assessing the Impact of Adverse Events on Cost-Effectiveness Results for NICE Single Technology Appraisals of Oncology Medicines

    Dec 1, 2023, 00:00

  • MSR15 The Impact of Response Assessment Timing on Indirect Treatment Comparisons (ITCS) – A Simulation Study

    Dec 1, 2023, 00:00

  • EE285 Economic Evaluation of Knee Arthroscopic Surgery: A Comparison of Ambulatory and In-Patient Knee Arthroscopic Surgery in Thailand

    Dec 1, 2023, 00:00

  • HSD88 The Propensity to Receive Haematopoietic Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma Patients Based on Sex, Ethnicity, and Deprivation: Results From National Cancer Registry Linked Real-World Datasets in England

    Dec 1, 2023, 00:00

  • HSD27 A 2013-2019 Comparative Study of Patient Safety Culture at 16 Hospitals in Shimane, Japan

    Dec 1, 2023, 00:00

  • HTA25 What Is a Highly Specialised Technology (HST)? The Revised NICE HST Criteria in Practice

    Dec 1, 2023, 00:00

  • EE235 Economic Evaluations of Medical Devices Used in the Treatment of Breast Cancer: A Systematic Review

    Dec 1, 2023, 00:00

  • HSD32 Long COVID: Clinical Characteristics and Management in the Real-World Setting

    Dec 1, 2023, 00:00

  • HTA328 An Updated Analysis of the Early Access Reform and Trends Observed in the Evaluation by the HAS

    Dec 1, 2023, 00:00

  • RWD68 How Pharmaceutical, Biotechnology and Medical Technology Companies Use Clinical Practice Research Datalink (CPRD) Data: Rapid Structured Review Using Machine Learning

    Dec 1, 2023, 00:00

  • CO30 Disease Burden and Efficacy of Current Treatment for Non-Neuronopathic MPS II Patients: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • PCR9 Rise of Undiagnosed Major Depressive Disorder Post-COVID-19 Pandemic in Europe

    Dec 1, 2023, 00:00

  • RWD55 Retrospective Observational Study of Real-World Treatment Patterns and Financial Burden in Patients With Premenopausal Metastatic HR+/HER2- Breast Cancer

    Dec 1, 2023, 00:00

  • HSD107 Descriptive Analysis of Changes to Cardiovascular Healthcare Resource Use Recorded in Malaysian Real World Data from the Syntium Database before, during and after the COVID-19 Pandemic

    Dec 1, 2023, 00:00

  • MSR58 It's Alive! Feasibility and Benefits of Living Cost-Effectiveness Modeling Following a Living SLR

    Dec 1, 2023, 00:00

  • HTA300 How Fast Will the EU HTA Child Grow? Estimation of the Number of Procedures in the First Years of Implementation

    Dec 1, 2023, 00:00

  • MT5 Mapping Facilities, Equipment and Trained Personnel of Radiotherapy in Greece

    Dec 1, 2023, 00:00

  • EE650 Incremental Costs of Tofacitinib Compared to Adalimumab and Ixekizumab for the Treatment of Active Ankylosing Spondylitis in Denmark

    Dec 1, 2023, 00:00

  • PCR91 Patients’ Needs in Assessing Long COVID: A Review of Relevant Concepts and Patient-Reported Outcomes

    Dec 1, 2023, 00:00

  • HTA279 Retrospective Analysis of the French Early Access Experience Following the 2021 Reform

    Dec 1, 2023, 00:00

  • EE209 Can the German Efficiency Frontier Approach Support Decision-Making Processes for Pricing New Medicines? An Application to Second-Line Interventions of Transplant-Ineligible Diffuse Large B-Cell Lymphoma

    Dec 1, 2023, 00:00

  • Patient-Centered Research

    Dec 1, 2023, 00:00

  • HTA326 Indication-Based Pricing of the Pharmaceuticals in Croatia: Case-Study Modelling Excercise

    Dec 1, 2023, 00:00

  • EPH34 Knowledge on HPV and Vaccination Among Undergraduates in Vojvodina

    Dec 1, 2023, 00:00

  • EPH98 Real-World Effectiveness and Safety of Tixagevimab-Cilgavimab: A Target Trial Emulation Study

    Dec 1, 2023, 00:00

  • EE162 Provider Budget Impact Model: Direct Transfer to Angiography Suite (DTAS) Without Stopping for CT Imaging for Patients With Acute Stroke in a German Setting

    Dec 1, 2023, 00:00

  • EE54 Costs of Proton Radiotherapy and Photon Radiotherapy for Non-Small Cell Lung Cancer in the Netherlands Using a Time-Driven Activity-Based Costing Approach

    Dec 1, 2023, 00:00

  • EPH85 Clinical Burden of GM2 Gangliosidoses in the United States (US): A Retrospective Observational Cohort Study Using Electronic Health Records (EHR)

    Dec 1, 2023, 00:00

  • RWD137 Real-World Osteoporosis Drug Utilization in Patients with Recurrent Osteoporotic Fracture: A Nationwide Cohort Study in South Korea

    Dec 1, 2023, 00:00

  • MSR71 Projecting the Potential Impact of Disease Modifying Therapy on the Future Health and Social Costs of Alzheimer’s Disease

    Dec 1, 2023, 00:00

  • The Role of Artificial Intelligen From Economic Modelling to Clinical Decision Making

    Dec 1, 2023, 00:00

  • HPR191 Incentives for Using Biosimilars in France and Europe: Analysis, Assessment and Perspectives

    Dec 1, 2023, 00:00

  • EE135 Efficiency Management of Immunization Programs in Peru, in the Context of the COVID-19 Pandemic: The Fully Liquid Acellular Hexavalent Vaccine

    Dec 1, 2023, 00:00

  • EE619 A Cost-Utility Analysis of Low-Dose vs Standard-Dose Intravenous Alteplase in the Management of Acute Non-Lacunar Ischaemic Strokes: A Perspective From the NHS

    Dec 1, 2023, 00:00

  • Differences and New Developments in HTA Around the World

    Dec 1, 2023, 00:00

  • HTA123 The View from the Sandbox: Implementing a Safe Space to Co-Develop and Test Innovations in HTA

    Dec 1, 2023, 00:00

  • HTA297 The Inclusion of Caregiver Burden in the National Institute for Health and Care Excellence (NICE) Health Technology Appraisals (HTAS) of Treatments for Mental Health Disorders

    Dec 1, 2023, 00:00

  • HTA156 Health Technology Assessment of Multiple Myeloma Therapies: Value Demonstration and Value Recognition Challenges

    Dec 1, 2023, 00:00

  • RWD141 How Global Datasets Can Shed Light on Health Inequalities: An Environmental Scan of Publicly Available Sources

    Dec 1, 2023, 00:00

  • HPR8 Drug Approvals for Advanced Breast Cancer in Brazil: Historical Perspective and Comparative Cost-Effectiveness Analysis

    Dec 1, 2023, 00:00

  • EPH52 Survey of Situation and Severity of Public Problems Affecting Health in an Industrial District in Thailand

    Dec 1, 2023, 00:00

  • EE640 The Impact of Blue-Light Emitting Device on the Loss of Productivity From COVID-19 in North Carolina

    Dec 1, 2023, 00:00

  • RWD54 Real-World Evidence for Patient Outcomes and Mutational Burden in Non-Small Cell Lung (NSCLC) Cancer Patients in England Using EGFR Biomarker Test Data from Routine Clinical Care

    Dec 1, 2023, 00:00

  • CO114 Comparative 30-Day Postoperative Outcomes between Robotic-Assisted Low Anterior Resection (RALAR) and Laparoscopic Low Anterior Resection (LLAR) Among Rectal Cancer Patients in Japan

    Dec 1, 2023, 00:00

  • HTA126 How Did French Health Technology Assessment Body (Transparency Committee, TC, of the HAS) Assess Drugs with Clinical Development Based on Single Arm Trials in the Last Three Years?

    Dec 1, 2023, 00:00

  • EPH236 Suicidal Behavior in Patients with Chronic Pain: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • EE338 Economic Impact of Herpes Zoster and Postherpetic Neuralgia on Healthcare Resource Use in Sweden

    Dec 1, 2023, 00:00

  • EE483 A Cost-Impact Analysis of a Novel Diagnostic Test to Assess Community-Acquired Pneumonia Etiology in the Emergency Departments: A French Perspective

    Dec 1, 2023, 00:00

  • EPH189 Factors Associated with Biosimilar Prescription for Anti-Cancer Biologics Among 58,915 Patients in Europe

    Dec 1, 2023, 00:00

  • A Longitudinal Evaluation of the Preferences of Patients With Advanced Cancer for Quality of Life and Survival in Malaysia: A Discrete Choice Experiment

    Dec 1, 2023, 00:00

  • EE136 The Socio-Economic Value of Adult Immunization: Results from a Comprehensive Literature Review of Four Immunization Programs in Ten Countries

    Dec 1, 2023, 00:00

  • HTA192 What Must Change if Future Evidence Pricing and Access Challenges Are to Be Successfully Overcome?

    Dec 1, 2023, 00:00

  • EE220 Cost-Effectiveness Analysis of Netupitant/Palonosetron for Chemotherapy Induced Nausea and Vomiting in Brazilian Private Healthcare System Perspective

    Dec 1, 2023, 00:00

  • PCR132 Correlation Between Quality of Life (QoL) of Patients Treated With Nivolumab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck (R/M SCCHN) and Their Caregivers

    Dec 1, 2023, 00:00

  • HTA10 Exploring the Impact of End-of-Life Designation on Access to Oncology Therapies in the United Kingdom

    Dec 1, 2023, 00:00

  • HTA133 The Number of NICE Appraisal Terminations Is Increasing, and Products With Multiple Indications Are Disproportionally Impacted

    Dec 1, 2023, 00:00

  • HTA34 Demonstrating Similar or Greater Health Benefits Based on Indirect Eviden A Review of NICE Evaluations That Include a Cost-Comparison Approach

    Dec 1, 2023, 00:00

  • EE517 Cost-Effectiveness Analysis of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Greece

    Dec 1, 2023, 00:00

  • RWD16 Identifying Oncology Effectiveness Endpoints Using Administrative Secondary Databases: An Example Utilising Hospital Episode Statistics in England

    Dec 1, 2023, 00:00

  • MT62 Virtual Reality Training on Medical Devices: A Proof of Concept Study

    Dec 1, 2023, 00:00

  • EE478 Obesity-Related Outcomes and Cost Impact of Weight Loss in Saudi Arabian Privately Insured Adults

    Dec 1, 2023, 00:00

  • P55 Prevalence and Predictors of Primary Non-Adherence to Medications Prescribed in Primary Care

    Dec 1, 2023, 00:00

  • EPH15 Transmission Dynamics and Vaccination Strategies for Chikungunya Virus (CHIKV): An Outbreak Simulation Study in Rome, Italy

    Dec 1, 2023, 00:00

  • MSR121 Use of External Control Arms in Pharmaceutical Submissions to the National Institute for Health and Care Excellence for Technology Appraisals: A Targeted Review

    Dec 1, 2023, 00:00

  • EE670 Management Costs of Grade 3/4 Adverse Events Associated with Emerging and Existing Systemic Therapies for Metastatic Colorectal Cancer with at Least Two Prior Lines of Therapy in Italy, Portugal, Spain, and the United States

    Dec 1, 2023, 00:00

  • PCR32 Patient Preference for Paroxysmal Nocturnal Haemoglobinuria Treatments: Analysis From the Q-Methodology of Treatment Attributes

    Dec 1, 2023, 00:00

  • EE410 Retrospective Database Analysis of Healthcare Resource Utilization and Costs in Patients With Vitiligo in Quebec, Canada

    Dec 1, 2023, 00:00

  • EE253 Comparative Efficacy of Beclomethasone/Formoterol/Glycopyrronium (BDP/FOR/GLY) Vs Budesonide/Glycopyrrolate/Formoterol (BUD/GLY/FOR): Indirect Comparison in Chinese Patients with Chronic Obstructive Pulmonary Disease

    Dec 1, 2023, 00:00

  • CO103 Modelled Impact of Nirsevimab for All Infants in Preventing Respiratory Syncytial Virus (RSV): Related Hospitalizations and Costs in the Brazilian Private Healthcare System

    Dec 1, 2023, 00:00

  • RWD64 A Nationwide Population-Based Study of Herbal Medicine for the Treatment of Functional Dyspepsia

    Dec 1, 2023, 00:00

  • EE417 Budget Impact of Efmoroctocog Alfa in Treatment of Severe Haemophilia a Patients in Turkey

    Dec 1, 2023, 00:00

  • RWD92 Evaluation of Second and Third Generation Tyrosine Kinase Inhibitor As First-Line Therapy for Non–Small-Cell Lung Cancer Patients: A Multi-Institutional Study in Taiwan

    Dec 1, 2023, 00:00

  • EE343 Cost-Utility and Cost-Effectiveness of Rapid Recovery After Joint Replacement: The Payer's Perspective

    Dec 1, 2023, 00:00

  • HTA162 Canadian HTA and Early-Phase Evidence in Oncology: Current Trends and the Path Ahead

    Dec 1, 2023, 00:00

  • PCR141 The Impact of Duchenne Muscular Dystrophy on Caregiver Employment: A Survey in Europe, Japan, and the United States

    Dec 1, 2023, 00:00

  • HTA31 Health Technology Assessment (HTA) of Clinical Care Pathways: Peritoneal Dialysis Versus Hemodialysis

    Dec 1, 2023, 00:00

  • PCR189 Health-Related Quality of Life and Its Drivers for Patients Living With Glioblastoma in Europe: A Systematic Review

    Dec 1, 2023, 00:00

  • EPH13 RSV Hospitalizations’ Burden in New-Born Patients and Potential Impact of Maternal Vaccination: A French Analysis

    Dec 1, 2023, 00:00

  • PCR221 Real-World Adherence to Anti-PCSK9 Monoclonal Antibody (mAb) and Its Impact on Economic Burden of Cardiovascular Diseases in Patients with Hypercholesterolemia: A Retrospective Cohort Study in China

    Dec 1, 2023, 00:00

  • PCR44 Work and Activity Impairment in Individuals With Chronic Kidney Disease According to Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Use

    Dec 1, 2023, 00:00

  • EE378 Real-World Data Establishing HCRU and Costs for the Treatment of Patients With Intermediate- to High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) Utilizing Medicare Claims Data

    Dec 1, 2023, 00:00

  • HTA173 Time to Access Orphan Medicines in Greece

    Dec 1, 2023, 00:00

  • EPH235 The Road to an HIV Cure: Approaches and Strategies in Current Clinical Trials

    Dec 1, 2023, 00:00

  • EE395 Economic Burden and Cost Drivers of Dystrophic Epidermolysis Bullosa: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • HTA270 Integrating Environmental Sustainability into HTA: The State of the Art and Possible Trajectories

    Dec 1, 2023, 00:00

  • EE425 Estimating HCP Labor Time and Cost Saving with the Use of Rapid Rituximab Infusions Versus Standard Rituximab Infusions for the Treatment of Adults with Follicular Lymphoma and Diffuse Large B-Cell Lymphoma in Induction Phase

    Dec 1, 2023, 00:00

  • EE740 Costs and Clinical Outcomes of Colorectal Cancer Surgeries: Results From the Emilia-Romagna Surgical Colorectal Audit (ESCA)

    Dec 1, 2023, 00:00

  • PCR33 The Application of Stated Preference Methods in Rare Disease: A Systematic Review

    Dec 1, 2023, 00:00

  • EE200 Cost of Illness of Spinal Muscular Atrophy in Turkey

    Dec 1, 2023, 00:00

  • MT77 Assessing the Environmental Impact Associated With Disruptive Surgical Bleeding

    Dec 1, 2023, 00:00

  • HSD9 Access to Precision Medicine in Mexico: Differences of Therapy Patterns for ALK+ and EGFR+ Non-Small Cell Lung Cancer (NSCLC) Patients

    Dec 1, 2023, 00:00

  • SA18 Public Health Economic Modelling in Evaluations of Salt and Alcohol Policies: A Scoping Review

    Dec 1, 2023, 00:00

  • SA38 Out-of-Pocket Expenses and Lost Earnings for Breast Cancer Patients Undergoing Treatment: Evidence From the UK Persephone Randomised Controlled Trial Abstract

    Dec 1, 2023, 00:00

  • EPH222 Temporal Analysis of Diabetes, Hypertension, and Asthma Prevalen A Comparative Study in European Countries (FRANCE, SPAIN, BELGIUM, ROMANIA, AND ITALY) Using a Real-World Ambulatory Medical Database (2018-2022)

    Dec 1, 2023, 00:00

  • MSR9 Adjusting for Switches to Multiple Treatments in Randomised Controlled Trials: A Comparison of Inverse Probability Weighting and Two-Stage Estimation Methods

    Dec 1, 2023, 00:00

  • HTA93 Time to Reimbursement of Novel Anticancer Drugs in Ireland Compared to Six European Countries and the UK

    Dec 1, 2023, 00:00

  • RWD135 A Demographic Description of Women With Uncomplicated Urinary Tract Infection in England: A Primary Care Electronic Health Records and Notes Review

    Dec 1, 2023, 00:00

  • PCR101 Patient-Centric-Approach and Personalized Clinical Trials to Increase Patients Participation in Drug Development: Insight from a Targeted Literature Review (TLR)

    Dec 1, 2023, 00:00

  • HPR14 Applications for Tafamidis (Vyndaqel®) Under a Managed Access Protcol in Ireland

    Dec 1, 2023, 00:00

  • EE592 Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Filipino Adults Aged ≥50 Years

    Dec 1, 2023, 00:00

  • MSR131 Prospects for Automation of Systemic Literature Reviews (SLRs) With Artificial Intelligence and Natural Language Processing

    Dec 1, 2023, 00:00

  • MSR128 Developing a Checklist to Increase Efficiency of VBA Code

    Dec 1, 2023, 00:00

  • PCR40 Unmet Medical Needs and Treatment Preferences for Systemic Treatments in Patients with Moderate to Severe Psoriasis: A Cross-Sectional Survey Study in China

    Dec 1, 2023, 00:00

  • EE746 Cost-Effectiveness of Vaccination Strategies to Control Future Mpox Outbreaks in England

    Dec 1, 2023, 00:00

  • MT29 Understanding How Health Technology Assessment Bodies Select Medical Technology for Review: Results of an Online Survey

    Dec 1, 2023, 00:00

  • SA20 The Effectiveness and Safety of Intra-Articular Injection Using Collagen in Knee Osteoarthritis: Systematic Review

    Dec 1, 2023, 00:00

  • EE552 Healthcare Resource Utilization in Alpha-Mannosidosis: Results from an International Caregiver Survey

    Dec 1, 2023, 00:00

  • CO48 A Systematic Review of Effectiveness and Safety of Acupuncture on Suicidal Behavior

    Dec 1, 2023, 00:00

  • HTA189 A Critical Appraisal of Economic Evaluations in RSV

    Dec 1, 2023, 00:00

  • MSR17 Can Machine Learning Accurately Predict Payer Behavior?

    Dec 1, 2023, 00:00

  • HTA254 Potential Discrepancies/Misalignments in Future EU-HTA Appraisals the POLIVY and Stelara JA3 PICO Example

    Dec 1, 2023, 00:00

  • HTA29 Analysis of the Change of the Added Benefit and Respective Reasons in Renewed Regular Benefit Assessments of Orphan Drugs Due to Exceeding the Sales Threshold in Germany

    Dec 1, 2023, 00:00

  • EE690 Assessing the Relative Budget Impact (BI) of PARP Inhibitor (PARPi) Combination Therapies for Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) with and Without BRCA1/2 Mutations

    Dec 1, 2023, 00:00

  • EE441 Estimating Changes in Lifetime Tax Revenue and Transfer Payments Associated with the Pediatric Immunization Program in Belgium

    Dec 1, 2023, 00:00

  • EE392 The Potential Impact of Delandistrogene Moxeparvovec on Work Productivity on Individuals With Duchenne Muscular Dystrophy in the United States (US)

    Dec 1, 2023, 00:00

  • MT57 Optimization of Patient Scheduling Based on AI Algorithm of the Radiotherapy Department of Liège University Hospital: Presentation of Selected Key Performance Indicators (KPIs) (HosmartAI - Horizon 2020 Funded)

    Dec 1, 2023, 00:00

  • MT8 Assessing Feasibility of Socially Assistive Humanoid Robots in Assisting in Nursing Routine

    Dec 1, 2023, 00:00

  • HTA325 Valuing Life - Decision-Making for Medicines in Australia: A Retrospective Analysis (2020-2022)

    Dec 1, 2023, 00:00

  • HPR111 ATMPs in Europe: Do We Have an Access Gap?

    Dec 1, 2023, 00:00

  • HPR84 Impact of AIFA Monitoring Registries Closure on Drugs’ Turnover Trends in Italy

    Dec 1, 2023, 00:00

  • HTA239 Network Meta-Analysis on the Efficacy and Safety of Drugs for the Treatment of Acute Myeloid Leukemia in the Elderly

    Dec 1, 2023, 00:00

  • EE8 Еconomic Evaluation of Intravascular Ultrasound (IVUS) for Imaging in Patients with Coronary Artery Disease in Bulgaria

    Dec 1, 2023, 00:00

  • HTA252 Shorter Time to Market for Pharmaceuticals Assessed in the Nordic HTA-Collaboration FINOSE

    Dec 1, 2023, 00:00

  • PCR178 Illness-Related Uncertainty in Relapsing-Remitting Multiple Sclerosis: Psychometric Properties of the MUIS Questionnaire

    Dec 1, 2023, 00:00

  • RWD166 Assessment of Haemophilia Management in Algeria: Challenges and Perspectives

    Dec 1, 2023, 00:00

  • HTA90 Quality of Clinical Evidence Submitted to a National HTA Agency in Ireland: 10 Years of Drugs for Oncology

    Dec 1, 2023, 00:00

  • HSD93 Towards Diagnosing Rare Diseases: Referral Behavior of Physicians in Europe

    Dec 1, 2023, 00:00

  • EE262 Indirect Cost Burden for Individuals Living with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in Europe

    Dec 1, 2023, 00:00

  • HSD62 The Emotional and Information Seeking Experience of Locally Advanced Cervical Cancer: Qualitative Research Findings from Brazil

    Dec 1, 2023, 00:00

  • RWD129 Cost Effectiveness of Onasemnogene Abeparvovec in Infants with Presymptomatic Spinal Muscular Atrophy in Italy

    Dec 1, 2023, 00:00

  • HPR51 Better Safe Than Sorry? Identification of Drug Combinations for Targeted Price Regulation in German Claims Data

    Dec 1, 2023, 00:00

  • HPR168 Assessment of Equity in Healthcare Financing for Uganda

    Dec 1, 2023, 00:00

  • RWD136 Use and Potential of Real-World Data (RWD) and Real-World Evidence (RWE) to Inform Pre-Market Regulatory Decisions: A Scoping Review

    Dec 1, 2023, 00:00

  • PCR64 EQ-5D Utility Scores in Patients With Clinically Suspect Arthralgia (CSA): Differences Between Progressors and Non-Progressors

    Dec 1, 2023, 00:00

  • HTA45 Study of HTA Timelines and Outcomes for MHRA-Approved NASs in the Post-Brexit UK via Reliance/Work-Sharing Routes

    Dec 1, 2023, 00:00

  • PT15 Comparing the Impact of Random Forest Vs Bayesian G-Computation on Matching-Adjusted Indirect Comparisons of Treatments Between Trials: A Simulation Study

    Dec 1, 2023, 00:00

  • EE699 Economic Burden of Propionic Acidemia by Age Stratum in the United States

    Dec 1, 2023, 00:00

  • MSR72 The Impact of Life Expectancy Exclusion Criteria on Survival Curve Extrapolation

    Dec 1, 2023, 00:00

  • EE663 The Disease and Economic Burden of Hepatocellular Carcinoma in Australia

    Dec 1, 2023, 00:00

  • EE576 Costs Saving Generated by Anti-TNF Biosimilars Market Penetration in Fran An Analysis Based on French Health Insurance Open Data

    Dec 1, 2023, 00:00

  • EE451 Methods to Measure the Environmental Impacts of Health Technologies and to Include Them in Economic Evaluations: A Scoping Literature Review

    Dec 1, 2023, 00:00

  • PCR73 Sensitivity of EQ-5D to Assess Health-Related Quality of Life (HRQoL) for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): KarMMa-3 Case Study Exploring EQ-5D Mapped from Disease-Specific Instruments

    Dec 1, 2023, 00:00

  • EE260 Cost-Effectiveness Analysis of Daratumumab Triplet Therapy Vs Carfilzomib Duplet Therapy in Patients with Relapsed or Refractory Multiple Myeloma in Egypt from Payer Perspective

    Dec 1, 2023, 00:00

  • EPH83 Ecological Study of the Incidence and Prevalence of Cancer Associated with Social Determinants of Health

    Dec 1, 2023, 00:00

  • MSR18 Modelling Challenges in Geographic Atrophy

    Dec 1, 2023, 00:00

  • HPR49 Clinical Rationales Support Access to Novel Combination Therapies in Oncology: Are We Trying to Play a New Game with the Old Rules?

    Dec 1, 2023, 00:00

  • MT58 Implications of VivaSight-DL: Procedural Impact of a Camera-Integrated Double Lumen Tube

    Dec 1, 2023, 00:00

  • EE539 The Economic Burden of Systemic Drug Therapy Administration Route in Treating HER2-Positive Breast Cancer for Patients, Healthcare Professionals, and Healthcare System: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • PT3 Concept Elicitation Interviews to Refine a Conceptual Model of the Patient Experience of Amyotrophic Lateral Sclerosis (ALS)

    Dec 1, 2023, 00:00

  • HSD120 Tafamidis in the Treatment of Transthyretin Amyloid Cardiomyopathy in Poland: Epidemiological Data and Demographic Data from an Expanded Access Program

    Dec 1, 2023, 00:00

  • HPR170 Time to Reimbursement in Ireland; Utilizing Regression Analysis to Assess Factors Contributing to Overall Timelines

    Dec 1, 2023, 00:00

  • HSD74 Cost Savings as a Result of Biosimilar Medications Adoption in One of the Tertiary Governmental Hospitals in Riyadh, Saudi Arabia.

    Dec 1, 2023, 00:00

  • PCR128 A Systematic Literature Review of Patient-Reported Outcomes With Nivolumab Across Gastric and Oesophageal Cancers

    Dec 1, 2023, 00:00

  • EPH223 Clinical, Economic, and Humanistic Burden of Atherosclerotic Cardiovascular Disease (ASCVD) and Familial Hypercholesterolemia (FH) in Latin America: A Scoping Review (SR)

    Dec 1, 2023, 00:00

  • EE399 Exploring the Economic Consequences of Caring for Patients With Rare Diseases: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • MT34 Adaptation and Cost-Effectiveness Analysis of the "My Health Everyday” Medication Adherence Coaching Application for Hypertension Management in Hungary

    Dec 1, 2023, 00:00

  • EE437 Cost-Utility Analysis of Acupotomy with Nerve Block Therapy from Lumbosacral Radiculopathy Patients in Korea

    Dec 1, 2023, 00:00

  • HTA111 Population, Intervention, Comparator, Outcomes (PICO) of ATMPs and Potential Impact on the Upcoming EU Regulation on HTA

    Dec 1, 2023, 00:00

  • EPH211 The Public Health Impact of mRNA-1273 Fall Booster Vaccination in the Netherlands

    Dec 1, 2023, 00:00

  • Impact of Regulatory Affairs on Access

    Dec 1, 2023, 00:00

  • EE84 Healthcare Resource Use and Cost in Metastatic Castration Resistant Prostate Cancer (mCRPC) in Finland

    Dec 1, 2023, 00:00

  • CO67 Development of an Investigator Global Assessment of Severity in Propionic Acidemia

    Dec 1, 2023, 00:00

  • EPH188 Social Determinants of Health and Treatment Receipt Among Privately and Publicly Insured Adults Diagnosed With Cancer in the United States

    Dec 1, 2023, 00:00

  • EE108 Cost-Effectiveness Analysis of Abrocitinib Versus Dupilumab for Treatment of Moderate-to-Severe Atopic Dermatitis in Chinese Adults

    Dec 1, 2023, 00:00

  • HTA103 Systematic Literature Reviews to Identify Clinical and Economic Outcomes in Adults With Pompe Disease

    Dec 1, 2023, 00:00

  • HTA310 Evolution of French Economic Opinions Published By the Economic Evaluation and Public Health (CEESP) in Oncology

    Dec 1, 2023, 00:00

  • MT50 Real-World Utilization and Outcomes of Transcatheter Mitral Valve Leaflet Repair (TMVLR) in Asian Patients with Mitral Regurgitation: A Singapore Experience

    Dec 1, 2023, 00:00

  • HPR64 Lack of Incentives, Lack of Sanctions, Lack of Complian Early Notification of Impending Drug Shortages in Eight European Countries

    Dec 1, 2023, 00:00

  • HTA180 Analyzing Transparency Committee Discussions: A Database Approach to Understanding Decision-Making Factors

    Dec 1, 2023, 00:00

  • HTA157 Reflection on Medicines That Have Recently Come Off Patent and Have Been Rejected by NICE in the Past 20 Years: A Case Study of Abiraterone for Treating Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer (MHSPC)

    Dec 1, 2023, 00:00

  • HTA241 Health Equity and the Health Technology Assessment Process: Are Children and Young People Being Overlooked? A Review of Pediatric National Institute of Health and Care Excellence Technology Appraisals

    Dec 1, 2023, 00:00

  • HSD8 Enhancing Prostate Cancer Care by Optimizing Patient Engagement with Digital Tools

    Dec 1, 2023, 00:00

  • MSR113 Inferring the Proportion of Durable Responders to Targeted Oncology Therapies in Combination Regimens Using Bayesian Parametric Mixture Survival Models

    Dec 1, 2023, 00:00

  • CO156 Direct Oral Anticoagulants in Adults with Non-Valvular Atrial Fibrillation: Systematic Review and Network Meta-Analysis of Real-World Evidence

    Dec 1, 2023, 00:00

  • EE598 Cost-Utility of Influenza Vaccination for the Brazilian Elderly Population With a High Dose Quadrivalent Vaccine in the Public Healthcare Sector

    Dec 1, 2023, 00:00

  • PCR77 Symptom Burden and Health-Related Quality of Life (HRQoL) in Gastrointestinal (GI) Cancers: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • EE488 Budget Impact Analysis of Oral Treatment With Nirmaltrevir+Ritonavir for COVID-19 in Argentina

    Dec 1, 2023, 00:00

  • EE14 Cost Effectiveness of Sensor Augmented Pump Therapy with Automated Insulin Suspension in the Management of Type 1 Diabetes (T1D) in Bulgaria

    Dec 1, 2023, 00:00

  • RWD26 Dupixam: An Algorithm to Identify Patients with Atopic Dermatitis Among Dupilumab-Treated Population Using the SNDS (SYSTEME NATIONAL DES DONNEES DE SANTE) in France

    Dec 1, 2023, 00:00

  • HTA276 Comparison of Health Technology Assessment Systems: A Review of Their Impact on Expenditure and Outcomes

    Dec 1, 2023, 00:00

  • EE398 Economic Burden of Wilson's Disease: A Systematic Review

    Dec 1, 2023, 00:00

  • RWD117 Comparison the Annual, Nationwide Health Insurance Treatment Cost of Hip Osteoarthritis Based on Routinely Collected Financing Data in 2010 and 2018 in Hungary

    Dec 1, 2023, 00:00

  • EE522 Cost-Effectiveness of Direct Oral Anticoagulants (DOACS) Versus Low-Molecular-Weight Heparins (LMWH) in Patients with Cancer-Associated Venous Thromboembolism (CAT) in Hong Kong

    Dec 1, 2023, 00:00

  • RWD128 The Burden of Illness in Duchenne Muscular Dystrophy: Evidence Gaps and Research Needs

    Dec 1, 2023, 00:00

  • Has the Centers for Medicare Medicaid Services Implicitly Adopted a Value Framework for Medicare Drug Price Negotiations? [Editor's Choice]

    Dec 1, 2023, 00:00

  • CO126 Effectiveness of Cell-Based Treatment Compared to Current Standard of Care for Knee Osteoarthritis Patients in the Netherlands

    Dec 1, 2023, 00:00

  • SA26 Prevalence and Burden of Lupus in Adult French Population: A Retrospective Longitudinal National Hospital Claims Study

    Dec 1, 2023, 00:00

  • EE330 Economic Burden of Biologic Therapy for Chinese Patients with Crohn's Disease

    Dec 1, 2023, 00:00

  • RWD4 Socioeconomic Burden of Obesity – Increased Rate and Duration of Sick Leave in Patients Living with Obesity: A Cross-Sectional Claims Data Analysis in Germany

    Dec 1, 2023, 00:00

  • EE718 Cost-Effectiveness of Medical Cannabis for Treatment of Chronic Pain: A Longitudinal Cohort Study of a Large German Hybrid Telemedicine Platform

    Dec 1, 2023, 00:00

  • EPH141 The Impact of Short Bowel Syndrome in Adult Patients in Portugal

    Dec 1, 2023, 00:00

  • HTA161 Can We Elicit a Willingness to Pay Threshold for Oncology Treatments in Denmark?

    Dec 1, 2023, 00:00

  • PCR96 Long Term Consequences of COVID-19 in Quality of Life in Patients Discharged From Hospital: Systematic Review

    Dec 1, 2023, 00:00

  • EPH268 Effectiveness of Pneumococcal Vaccination in Older Adults in a Real-World Setting: A Systematic Review and Meta-Analysis of Observational Studies Using Test-Negative Designs

    Dec 1, 2023, 00:00

  • EPH156 Modelling Herpes Zosters Burden and Public Health Impact of Adjuvanted Recombinant Zoster Vaccine Among Adults Aged ≥50 Years Old in Seven Countries in Central and South America

    Dec 1, 2023, 00:00

  • MSR160 Screening Tools for Streamlining Systematic Literature Review Process: Reviewers' Perspective

    Dec 1, 2023, 00:00

  • Advancements in Digital Health Interventions: Evidence Syntheses, Value Assessment, and Global Perspectives

    Dec 1, 2023, 00:00

  • EE702 Humanistic and Economic Burden of Methylmalonic Acidemia—A Systematic Literature Review

    Dec 1, 2023, 00:00

  • HTA142 Evolution of French Economic Opinions Published by the Economic Evaluation and Public Health Committee (CEESP)

    Dec 1, 2023, 00:00

  • EE129 Health-Economic Analysis of Digestive Stents in France Based on the French Social Insurance Healthcare Database

    Dec 1, 2023, 00:00

  • RWD81 Annual Nationwide Epidemiological and Health Insurance Burden of Hip Osteoarthritis in Hungary: A Burden of Disease Study Based on Real World Data

    Dec 1, 2023, 00:00

  • Preferences for Palliative and End-of-Life Care: A Systematic Review of Discrete Choice Experiments [Editor's Choice]

    Dec 1, 2023, 00:00

  • EPH266 Mechanisms of HPV Vaccine Knowledge Levels Under Restricted Supply of Nine-Valent Vaccine in China Mainland

    Dec 1, 2023, 00:00

  • EE195 Quantifying the Avoided Costs of a Switch to Ofatumumab From Low/Moderate Efficacy Disease Modifying Therapies in Patients With Relapsing-Remitting Multiple Sclerosis in Colombia

    Dec 1, 2023, 00:00

  • EE495 Cost of Spinal Muscular Atrophy(SMA) Management in Turkiye

    Dec 1, 2023, 00:00

  • PCR137 Understanding the Signs, Symptoms and Impacts of Metachromatic Leukodystrophy (MLD)

    Dec 1, 2023, 00:00

  • EE371 Economic Evaluation of Anaplastic Lymphoma Kinase (ALK) Inhibitors Compared with Standard Chemotherapy in Thailand

    Dec 1, 2023, 00:00

  • HTA361 Living Systematic Review (LSR) in Health Technology Assessment (HTA): Current Guidance, Methods, and Challenges

    Dec 1, 2023, 00:00

  • MSR100 Exploring Methods to Include Carbon Footprint into an HTA: The Case of Remote Patient Management

    Dec 1, 2023, 00:00

  • EPH199 Factors Associated With Hospitalization for E-Cigarette/Vaping Associated Lung Injury (EVALI) in the United States

    Dec 1, 2023, 00:00

  • HTA283 A Scoping Review of Health Technology Assessment Agency (HTA) and Health Economic (HE) Modelling Guidelines for Identification of Health Economic Model Inputs

    Dec 1, 2023, 00:00

  • EPH272 It Is Known Since 1922 at 2B Level of Evidence, Yet Not Used: Attitude Towards Intraosseous Medication

    Dec 1, 2023, 00:00

  • OP17 Mapping Pharma Market Access Executives in Greece

    Dec 1, 2023, 00:00

  • HSD128 Preferences of Healthcare Providers in Switzerland for Attributes of Pediatric Hexavalent Vaccines

    Dec 1, 2023, 00:00

  • EE177 Cost-Effectiveness Modelling in Moderate to Severe Ulcerative Colitis: Novel Approaches to Capture Variable Induction Periods, Treatment Sequences, and Variable Treatment Cycle Lengths

    Dec 1, 2023, 00:00

  • EE712 Budget Impact Analysis of Faricimab for Treating Patients With Diabetes Macular Edema or Neovascular Age-Related Macular Degeneration in El Salvador, Honduras, and Dominican Republic

    Dec 1, 2023, 00:00

  • Innovations in Modeling for Health Technology Assessment

    Dec 1, 2023, 00:00

  • HTA319 3-Year Report Card: RWE Collection in Germany

    Dec 1, 2023, 00:00

  • EE596 Cost-Effectiveness and Public Health Impact of a Nine-Valent Human Papillomavirus Vaccination Program in Ukraine

    Dec 1, 2023, 00:00

  • MSR140 Current Trends in Survival Extrapolation Methods: A Review of NICE Health Technology Appraisals for Oncology Drugs

    Dec 1, 2023, 00:00

  • EPH253 Epidemiology Disease Burden of Polycistic Ovary Syndrome Based on Routinely Collected Health Insurence Claims Data Between 2010-2019

    Dec 1, 2023, 00:00

  • HTA324 Recent Landscape of Drug Re-Assessments by G-BA – What Is the Impact of New Evidence on the Benefit Assessment Outcome?

    Dec 1, 2023, 00:00

  • HSD14 X-Linked Retinitis Pigmentosa Impacts Patients’ Independence, Work Status, and Quality of Life: Insights from the Cross-Sectional Explore Xlrp-1.2 Physician Survey

    Dec 1, 2023, 00:00

  • PCR98 Reduced Dialysis Adherence and Greater Medication Use Associated with Increased Itch Severity

    Dec 1, 2023, 00:00

  • HSD75 Optimizing Preoperative Assessment Through a Digital Healthcare Platform for Triage and Stratification in Joint Replacement Surgery: A Real-World Evaluation

    Dec 1, 2023, 00:00

  • RWD89 Economic Burden of Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring KRASG12C Mutation in Spain

    Dec 1, 2023, 00:00

  • EPH20 Muscular Dystrophy-Related Hospitalizations and Outpatient Procedures in the Brazilian Public Healthcare System: A Real World Data Analysis

    Dec 1, 2023, 00:00

  • EPH76 Triptan Switches for Danish Migraine Patients Treated With at Least Three Distinct Triptans Before Discontinuation—A Register Based Study

    Dec 1, 2023, 00:00

  • EE381 Health Benefits and Cost-Effectiveness Analysis of Early Breast Cancer Diagnosis in Bulgaria

    Dec 1, 2023, 00:00

  • HTA146 Early Access in Fran Reasons for Refusals and Impact on Market Access

    Dec 1, 2023, 00:00

  • EE272 Cost-Effectiveness of Voclosporin in Combination with Mycophenolate Mofetil for Active Lupus Nephritis in Sweden

    Dec 1, 2023, 00:00

  • SA23 Bruton Tyrosine Kinase Inhibitor (BTKi) Monotherapy for the Treatment of ‘High-Risk’ Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): A Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00

  • P24 Improving Efficiency of Living Systematic Literature Reviews (SLR) with Artificial Intelligence (AI): Assisted Extraction of Population, Intervention/Comparator, Outcome, and Study Design (P-I/C-O-S)

    Dec 1, 2023, 00:00

  • EE727 The Budgetary Impact of Introducing Expanded Haemodialysis, Enabled by Theranova (HDX), Compared to High-Flux Haemodialysis (HF-HD) in Private Sector in the Kingdom of Saudi Arabia

    Dec 1, 2023, 00:00

  • MSR75 Correlate: Assessing Dose Effect Using Targeted Maximum Likelihood Estimation (TMLE)

    Dec 1, 2023, 00:00

  • CO91 Association Between Progression-Free Survival (PFS) and Overall Survival (OS) in Patients with Relapsed/Refractory (RR) Multiple Myeloma (MM)

    Dec 1, 2023, 00:00

  • HTA57 Costing for Health Economics Evaluation: The Case of the Brazilian Universal Health System

    Dec 1, 2023, 00:00

  • HTA165 Unmet Medical Need in Norwegian Clinical Practice and Cost-Effectiveness Analysis of Polatuzumab in Combination With R-CHP Compared to R-CHOP in Patients With Previously Untreated DLBCL With an IPI Score of Three and Above

    Dec 1, 2023, 00:00

  • HSD72 Improving Patient Care for Chronic Kidney Disease-Related Anemia in Italy: A Survey to Evaluate the Nephrological Card As a Tool for Optimizing Treatment Pathway

    Dec 1, 2023, 00:00

  • HPR24 Utilisation and Expenditure on Blood Glucose Test Strips in Ireland—The Impact of Health Technology Management in Reducing and Containing Expenditure

    Dec 1, 2023, 00:00

  • RWD178 Real-World Evidence in Post-Authorization Studies: Review of European Databases in the ENCePP EU Pas Register® Between 2010 – 2023

    Dec 1, 2023, 00:00

  • Novel Approaches to Patient Communication, Data Collection, and Involvement in Research

    Dec 1, 2023, 00:00

  • MT25 What Evidence Should Medical Technology Companies Expect HTA Bodies to Review?

    Dec 1, 2023, 00:00

  • HPR129 Catastrophic Health Expenditure: A Comparative Analysis of in Elderly Household and Non-Elderly Household in Korea

    Dec 1, 2023, 00:00

  • EPH218 Knowledge of Contraception and Sexually Transmitted Diseases Regarding the Quality of Education and Parent-Child Relationship Among Secondary School Students

    Dec 1, 2023, 00:00

  • EE369 Cost-Effectiveness Analysis of Pembrolizumab as a Second-Line Therapy for Advanced Urothelial Carcinoma in the United States

    Dec 1, 2023, 00:00

  • EE741 Costs of Breast Surgery Reconstruction and Mastectomy in France between 2019 and 2021

    Dec 1, 2023, 00:00

  • HSD41 Healthcare Models for Rare Diseases: A Systematic Literature Review for the Development of a Comprehensive Model in a Latin American Country

    Dec 1, 2023, 00:00

  • Clinical Outcomes

    Dec 1, 2023, 00:00

  • PCR152 Exploring Which Proxy Conditions Are Conceptually Similar to Alopecia Areata, in Terms of Patients Lived Experience and Health-Related Quality of Life: A Scoping Review to Inform HTA Submission

    Dec 1, 2023, 00:00

  • MSR93 Hype, Not Hope: Using Bayesian Methods in Drug Development

    Dec 1, 2023, 00:00

  • RWD96 Burden of Chronic Obstructive Pulmonary Disease (COPD) Patients Uncontrolled Despite Triple-Therapy in France

    Dec 1, 2023, 00:00

  • RWD27 Opportunities and Challenges in Linkage of Early Access Databases With the French National Claims Database: A RWE Effectiveness Study of AZD7442 for Pre-Exposure Prophylaxis Against COVID-19 in Immunocompromised Patients

    Dec 1, 2023, 00:00

  • HSD6 The CONNACT Program for Knee Osteoarthritis Can Potentially Lower 2-Year Costs of Outpatient Treatment

    Dec 1, 2023, 00:00

  • EE46 BoNT-As for Cervical Dystonia: Cost of Treatment and Response to Therapy in Canadian Patients

    Dec 1, 2023, 00:00

  • HSD89 The Operational Effectiveness of Using an M L-Driven Patient Medical Record: A Simulated Comparative Study Using Real-World Data

    Dec 1, 2023, 00:00

  • HTA112 The NICE Medical Technologies Evaluation Program: An Analysis of Clinical and Economic Evidence Evaluated in Published Medical Technology Guidance

    Dec 1, 2023, 00:00

  • HTA66 Review and Analysis of Economic Model Characteristics According to Published HTA Conclusions in Ukraine

    Dec 1, 2023, 00:00

  • EE140 Comparison of the Clinical and Economic Impact of Two MRNA COVID-19 Vaccines in High Risk Individuals in Japan

    Dec 1, 2023, 00:00

  • EE82 A Cost-Utility Analysis of the MyPal eHealth Application, an ePro Intervention Aiming to Foster Palliative Care of Cancer Patients: Results From a Randomized Clinical Trial in 4 European Countries

    Dec 1, 2023, 00:00

  • HTA138 Impact of Publication of the French Commission for Economic and Public Health Evaluation (CEESP) Doctrine on French Medico-Economic Evaluation – a Quantitatve Analysis

    Dec 1, 2023, 00:00

  • CO6 Teduglutide for Treating Short-Bowel Syndrome in Adults: A Meta-Analysis of Real-World Evidence Compared to Clinical Trial Data

    Dec 1, 2023, 00:00

  • RWD121 Moment Registry (MET NON SMALL CELL CANCER REGISTRY) for Advanced Non-Small Cell Lung Cancer (ANSCLC) Harboring MET Exon 14 (METEX14) Skipping

    Dec 1, 2023, 00:00

  • EE361 From Biobank Sample to Breast Cancer Prevention—Cost-Effectiveness Analysis of Returning Genomic Data to Sample Donors

    Dec 1, 2023, 00:00

  • PT28 Lost in PICO? a Simulation of the EU HTA Scoping Process

    Dec 1, 2023, 00:00

  • EE363 Cost-Effectiveness Analysis of Adding Tumor Treating Fields Therapy to Temozolomide Versus Temozolomide Only in Patients with Glioblastoma in France

    Dec 1, 2023, 00:00

  • MT32 Predictive Factors of Communicating Health-Related Information through the Internet Among Adults in South Korea: A Cross-Sectional Study

    Dec 1, 2023, 00:00

  • EPH89 Epidemiological Disease Burden of Female Infertility, N.O.S, Based on Routinely Collected Health Insurance Claims Data Between 2010-2019

    Dec 1, 2023, 00:00

  • EPH40 Evolving Impact of the COVID-19 Pandemic in Chronic Dialysis Recipients According to Wave Sub-Periods

    Dec 1, 2023, 00:00

  • SA55 Whole-Body MRI Accuracy and Cost-Effectiveness Compared with Standard Pathways for Detecting and Monitoring Bone Metastases in Prostate Cancer: A Systematic Review

    Dec 1, 2023, 00:00

  • HPR67 Utilisation of Intermittent and Real-Time Continuous Blood Glucose Monitoring in the Irish Healthcare System

    Dec 1, 2023, 00:00

  • EPH4 Burden of Disease and Cost of Permanent Productivity Loss of Cardiovascular Disease (CVD) in South America (SA)

    Dec 1, 2023, 00:00

  • OP24 Collaborating for Better Outcomes: How Can Value-Based Partnerships Unlock Value Across Stakeholder Groups and Elevate Pharma's Role Within Healthcare Ecosystems?

    Dec 1, 2023, 00:00

  • EPH48 Targeted Influenza Vaccination in at Risk Populations – How Avoided Cases Translate into Clinical and Economic Benefits for Czech Republic, Hungary, and Romania

    Dec 1, 2023, 00:00

  • PCR15 Impact of Amyotrophic Lateral Sclerosis on Work and Daily Living: Results from a Real-World Survey

    Dec 1, 2023, 00:00

  • PCR127 Needs and Experiences of Patients and Healthcare Professionals Towards Shared Decision Making in Multiple Myeloma Clinical Practi A Qualitative Study in Europe

    Dec 1, 2023, 00:00

  • CO11 Medication Adherence in Osteoporosis Treatments and the Impact in Patients' Quality of Life

    Dec 1, 2023, 00:00

  • CO90 Augmenting Synthetic Control Arms Using Bayesian Borrowing: A Case Study in First-Line Non-Small Cell Lung Cancer

    Dec 1, 2023, 00:00

  • EPH247 Survival and Risk of Death Analysis of Patients with Myelofibrosis Treated with Ruxolitinib

    Dec 1, 2023, 00:00

  • PCR65 Assessment of the EQ-5D and DMD-QoL for Duchenne Muscular Dystrophy: A Patient and Caregiver Study

    Dec 1, 2023, 00:00

  • HSD34 Real-World Usage of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with Axial Spondyloarthritis in Germany

    Dec 1, 2023, 00:00

  • MSR95 Simulated Treatment Comparison or Matching-Adjusted Indirect Comparison: Which Wins in the Battle for Prominence and Validity in Population-Adjusted Indirect Treatment Comparison?

    Dec 1, 2023, 00:00

  • HSD103 Lifestyle Modifications and Medicines as the Foundation of Clinical Practice Guidelines

    Dec 1, 2023, 00:00

  • EE265 Cost-Effectiveness of Efmoroctocog Alfa in Treatment of Severe Hemophilia A Patients in Turkey

    Dec 1, 2023, 00:00

  • EE519 Do We Need Three-State Decision Analytic Models in Metastatic Oncology? An Alternative Approach to Estimate Quality Adjusted Life Years (QALY)

    Dec 1, 2023, 00:00

  • Cover

    Dec 1, 2023, 00:00

  • HTA159 Review of Survival Modeling Approaches Adopted in NICE Technology Appraisals (TAs) in Non-Small Cell Lung Cancer (NSCLC)

    Dec 1, 2023, 00:00

  • PCR194 A Global Perspective on Self-Reported Productivity Losses Associated With Osteogenesis Imperfecta

    Dec 1, 2023, 00:00

  • HPR11 Oncolytic Therapies in China: Laying the Groundwork for a Successful Launch

    Dec 1, 2023, 00:00

  • EE196 Real World Evidence on the Burden of Disease for Patients and Their Nearest Relatives - the Case of Duchenne Muscular Dystrophy

    Dec 1, 2023, 00:00

  • EE426 The Acceptance of Indirect Treatment Comparisons in Pharmacoeconomic Analyses by the Dutch Healthcare Institute (ZIN)

    Dec 1, 2023, 00:00

  • EE166 Healthcare Resource Use and Economic Burden of Stroke Among People with Type 2 Diabetes: A Real-World Evidence Study in France

    Dec 1, 2023, 00:00

  • EE714 A De Novo Cost-Effectiveness Model to Evaluate the Real-World Value of Pegcetacoplan in the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration in the United States

    Dec 1, 2023, 00:00

  • MSR141 Identifying and Extrapolating Immature OS Data in Survival Analysis: A Review of the Variation in Methods Used in Oncology STAs for NICE

    Dec 1, 2023, 00:00

  • An Updated Review of Food and Drug Administration Warning and Untitled Letters for Clinical Outcome Assessment Claims Between 2013 and 2021

    Dec 1, 2023, 00:00

  • RWD126 Assessment of Cutaneous Malignant Melanoma Knowledge, Tanning Attitude, and Sun-Protective Behavior in Gree A Significant Gap in the National Preventive Health Strategy

    Dec 1, 2023, 00:00

  • PCR45 Vascular Access Devices: A Comparative Analysis of Complications and Their Cost Implications

    Dec 1, 2023, 00:00

  • P35 How Perspective Affects the Cost-Effectiveness of Remote Patient Monitoring for Patients With Heart Failure in Different European Countries

    Dec 1, 2023, 00:00

  • HSD42 The Humanistic Impact of X-Linked Retinitis Pigmentosa (XLRP): Results from the Explore Xlrp-2 Retrospective Chart Review and Cross-Sectional Survey of Patients and Caregivers in 10 Countries

    Dec 1, 2023, 00:00

  • EE186 A Comparative Cost Analysis between Dalbavancin, Oritavancin and Delafloxacin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Spain

    Dec 1, 2023, 00:00

  • MT36 Roadmap for Evidence Generation on Remote Monitoring Devices for Parkinson’s Disease

    Dec 1, 2023, 00:00

  • HTA334 Assessment of Vaccines in Europe, the HPV Example: Can the EU Joint Clinical HTA Regulation Result in More Consistent Vaccine Evaluations and Improve Access Across EU Countries?

    Dec 1, 2023, 00:00

  • HTA348 How to Align EU HTA with National Market Access?

    Dec 1, 2023, 00:00

  • EPH157 Developing an Analysis to Determine the Value of Time When Delaying the Who's Seasonal Influenza Vaccine Strain Selection Recommendation

    Dec 1, 2023, 00:00

  • CO143 Identifying Evidence Gaps for Hemophilia B by Developing a Factsheet Using Targeted Review of Literature: Shaping the Future Real-World Evidence Studies

    Dec 1, 2023, 00:00

  • RWD86 Characteristics of Patients with Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Who Received Pembrolizumab as Part of an Early Access Program in Accordance with KN-355 Labelling

    Dec 1, 2023, 00:00

  • HPR76 Financial Feasibility Study of Incremental Modified Drugs Development by Domestic Pharmaceutical Industry

    Dec 1, 2023, 00:00

  • HSD115 Genetic Testing in Chinese Breast Cancer Patients: A Survey on Knowledge, Receipt, and Willingness to Pay

    Dec 1, 2023, 00:00

  • EPH150 Impact CKD: The Growing Burden of CKD in Spain

    Dec 1, 2023, 00:00

  • HPR160 An Ecological Study of 4 Drug Categories Consumption Inequities in Spain

    Dec 1, 2023, 00:00

  • HPR171 WTP Threshold: A Review of International Approaches and Inspiration for Cultivation of Current Situation in the Czech Republic

    Dec 1, 2023, 00:00

  • MSR155 Identifying Relevant Clinical Regulatory and Health Technology Assessment (HTA) Precedents via Artificial Intelligence (AI)

    Dec 1, 2023, 00:00

  • MSR122 Relationship Between 3-Meter Backward Walk Test and Grip Strength Test in Community-Dwelling Young-Older Adults

    Dec 1, 2023, 00:00

  • PCR34 The Humanistic and Economic Burden of Illness in Progressive Fibrosing Idiopathic Lung Disease: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • CO136 Systematic Literature Review (SLR) of Clinical Data in Third-Line and Beyond (3L+) Small Cell Lung Cancer (SCLC) Patients

    Dec 1, 2023, 00:00

  • PCR170 The Prevalence and Factors That Affect Perceived Stress, Anxiety, and Depression Among IBD Patients

    Dec 1, 2023, 00:00

  • CO76 Does Next Generation Sequencing (NGS) Improve Outcome in Non-Small Cell Lung Cancer (NSCLC)? A Real-World Data (RWD) Example

    Dec 1, 2023, 00:00

  • EE547 The Societal Costs of Metachromatic Leukodystrophy (MLD) in the United States

    Dec 1, 2023, 00:00

  • HTA364 Can Artificial Intelligence and Machine Learning Be Used to Demonstrate the Value of a Technology for HTA Decision-Making?

    Dec 1, 2023, 00:00

  • HPR108 Managed Entry Agreements and Appropriateness Tools Over the Last Three Years in Italy

    Dec 1, 2023, 00:00

  • HTA27 Use of Clinical Outcome Assessments in Health Technology Appraisals for Rare Disease Indications: A Review of UK, US, and Canadian Submissions

    Dec 1, 2023, 00:00

  • EPH113 Assessment of the Quality of Life in Patients With Acute Ischemic Stroke Diagnosed With Brainomix Artificial Intelligence-Based System, Under Different Therapeutic Approaches (Standard Treatment, Thrombolysis, Thrombectomy)

    Dec 1, 2023, 00:00

  • EE664 Total Direct Costs of Ovarian Cancer in Colombia: A National Cohort Study Based on Administrative Claims Databases

    Dec 1, 2023, 00:00

  • HPR23 Preparing Healthcare Systems for Broader Cell Gene Therapy (CGT) Access: What Needs to Change for Pharma, Healthcare Systems, and Patients so All Benefit From CGTs?

    Dec 1, 2023, 00:00

  • EPH140 Prevalence Estimation of Thymidine Kinase 2 Deficiency: An Ultra-Rare Autosomal Recessive Mitochondrial Disease

    Dec 1, 2023, 00:00

  • RWD165 Improving Evidence Generation From Rare Disease Registries: Performing Variable Gap Analyses

    Dec 1, 2023, 00:00

  • EPH240 Epidemiology, Economic Burden, and Humanistic Burden in Multiple Sclerosis Spasticity (MSS): A Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00

  • HTA64 Surrogate Endpoints Used in NICE Technology Appraisals for Oncology and Non-Oncology Indications, 2022–23

    Dec 1, 2023, 00:00

  • OP23 Best Practice for Publication of Health Economics and Outcomes Research/Real-World Evidence (RWE) - a Pilot Study on Guidance Needs and Scope for Development

    Dec 1, 2023, 00:00
  • «
  • 11
  • 12
  • 13
  • 14
  • 15 (current)
  • 16
  • 17
  • 18
  • 19
  • 20
  • »